S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Silvio K. Garattini · Study
Home
/
Author
Silvio K. Garattini
21 works
· latest 2019
· 2 institutions
cluster: provisional
ORCID 0000-0003-0647-9297
Follow
Suggest an ORCID correction
h-index
19
i10
19
Citations
1,667
Works here
21
99
00
01
05
06
07
08
09
10
12
14
15
16
17
18
19
Most cited in this library
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
2010 · 255 citations
Outrageous prices of orphan drugs: a call for collaboration
2018 · 158 citations
Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates
1999 · 111 citations
Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
2012 · 111 citations
Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
2005 · 109 citations
Works
21 shown
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval
British Journal of Clinical Pharmacology
·
2019
·
5 authors
·
Open access
59
citations
Outrageous prices of orphan drugs: a call for collaboration
The Lancet
·
2018
·
19 authors
158
citations
Can systematic reviews contribute to regulatory decisions?
European Journal of Clinical Pharmacology
·
2017
·
5 authors
·
review
8
citations
Ethics of reviewing scientific publications
European Journal of Internal Medicine
·
2016
·
3 authors
·
Open access
33
citations
Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them
European Journal of Internal Medicine
·
2016
·
18 authors
·
review
·
Open access
109
citations
Approvals of drugs with uncertain benefit–risk profiles in Europe
European Journal of Internal Medicine
·
2015
·
4 authors
·
Open access
93
citations
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders
Journal of Comparative Effectiveness Research
·
2014
·
12 authors
·
Open access
73
citations
Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
European Journal of Clinical Pharmacology
·
2012
·
3 authors
111
citations
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
BMC Health Services Research
·
2010
·
16 authors
·
review
·
Open access
255
citations
Orphan drug development is not taking off
British Journal of Clinical Pharmacology
·
2009
·
3 authors
·
editorial
·
Open access
63
citations
Enhancing the rational use of new medicines across European health care systems
European Journal of Clinical Pharmacology
·
2008
·
6 authors
·
editorial
·
Open access
71
citations
Italy must invest more in science and technology
Nature
·
2008
·
3 authors
4
citations
Having Your Cake and Eating It
PharmacoEconomics
·
2008
·
5 authors
·
review
49
citations
How can we regulate medicines better?
BMJ
·
2007
·
2 authors
·
Open access
58
citations
Orphan drug development is progressing too slowly
British Journal of Clinical Pharmacology
·
2006
·
3 authors
·
Open access
70
citations
Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
British Journal of Cancer
·
2005
·
4 authors
·
Open access
109
citations
Adjusting Europe's drug regulation to public health needs
The Lancet
·
2001
·
2 authors
70
citations
Health-Related Quality of Life (HR-QOL) and Regulatory Issues
PharmacoEconomics
·
2001
·
4 authors
87
citations
The risk of bias from omitted research
BMJ
·
2000
·
1 author
·
editorial
·
Open access
23
citations
Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates
Social Psychiatry and Psychiatric Epidemiology
·
1999
·
5 authors
111
citations
Are me-too drugs justified?
PubMed
·
1997
·
1 author
53
citations